Sort   by:  
 Page size 
UnknownEffects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
Not available
S-EPMC7660824 | biostudies-literature
UnknownPDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury.
Not available
S-EPMC9707286 | biostudies-literature
UnknownComparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
Not available
S-EPMC5444673 | biostudies-literature
UnknownSemaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
Not available
S-EPMC10792518 | biostudies-literature
UnknownGranulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
Not available
S-EPMC5738975 | biostudies-literature
UnknownFibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Not available
S-EPMC7066580 | biostudies-literature
UnknownAdministrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.
Not available
S-EPMC8515502 | biostudies-literature
UnknownOutcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Not available
S-EPMC6656693 | biostudies-literature
UnknownNamilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.
Not available
S-EPMC8676420 | biostudies-literature
UnknownThe impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.
Not available
S-EPMC11252535 | biostudies-literature
Sort   by:  
 Page size